BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 15052206)

  • 61. Factors associated with false-positive staging of lung cancer by positron emission tomography.
    Roberts PF; Follette DM; von Haag D; Park JA; Valk PE; Pounds TR; Hopkins DM
    Ann Thorac Surg; 2000 Oct; 70(4):1154-9; discussion 1159-60. PubMed ID: 11081861
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diffusion-weighted imaging can correctly identify false-positive lymph nodes on positron emission tomography in non-small cell lung cancer.
    Nomori H; Cong Y; Sugimura H; Kato Y
    Surg Today; 2016 Oct; 46(10):1146-51. PubMed ID: 26658716
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of positron emission tomography in mediastinal staging of patients with non-small cell lung cancer.
    d'Amico A; Turska-d'Amico M; Jarzab B; Zielinski M
    J Pak Med Assoc; 2015 Jan; 65(1):35-8. PubMed ID: 25831671
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group.
    Scott WJ; Schwabe JL; Gupta NC; Dewan NA; Reeb SD; Sugimoto JT
    Ann Thorac Surg; 1994 Sep; 58(3):698-703. PubMed ID: 7944691
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers.
    Bryant AS; Cerfolio RJ
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1363-8. PubMed ID: 17140957
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study.
    Loft A; Berthelsen AK; Roed H; Ottosen C; Lundvall L; Knudsen J; Nedergaard L; Højgaard L; Engelholm SA
    Gynecol Oncol; 2007 Jul; 106(1):29-34. PubMed ID: 17482666
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer.
    Vesselle H; Pugsley JM; Vallières E; Wood DE
    J Thorac Cardiovasc Surg; 2002 Sep; 124(3):511-9. PubMed ID: 12202868
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer.
    Chang CH; Wu HC; Tsai JJ; Shen YY; Changlai SP; Kao A
    Urol Int; 2003; 70(4):311-5. PubMed ID: 12740497
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET.
    Nambu A; Kato S; Sato Y; Okuwaki H; Nishikawa K; Saito A; Matsumoto K; Ichikawa T; Araki T
    Ann Nucl Med; 2009 May; 23(3):269-75. PubMed ID: 19340527
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of ultrasound-guided fine needle aspiration in assessing the impalpable cervical node with increased 18F-fluorodeoxyglucose uptake on positron emission tomography scanning: preliminary communication.
    Wang CP; Lee CY; Lou PJ; Yen RF; Hsiao JK; Ko JY
    J Laryngol Otol; 2008 Dec; 122(12):1349-53. PubMed ID: 18549513
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Siewert type I and II oesophageal adenocarcinoma: sensitivity/specificity of computed tomography, positron emission tomography and endoscopic ultrasound for assessment of lymph node metastases in groups of thoracic and abdominal lymph node stations.
    Lopci E; Kauppi J; Lugaresi M; Mattioli B; Daddi N; Fortunato F; Rasanen J; Mattioli S
    Interact Cardiovasc Thorac Surg; 2019 Apr; 28(4):518-525. PubMed ID: 30496443
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combined procedures for mediastinal staging in non-small cell lung cancer.
    Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
    Asian Cardiovasc Thorac Ann; 2004 Jun; 12(2):125-9. PubMed ID: 15213078
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mediastinal lymph node evaluation by computed tomographic scan in lung cancer.
    Kamiyoshihara M; Kawashima O; Ishikawa S; Morishita Y
    J Cardiovasc Surg (Torino); 2001 Feb; 42(1):119-24. PubMed ID: 11292919
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck.
    Schmid DT; Stoeckli SJ; Bandhauer F; Huguenin P; Schmid S; von Schulthess GK; Goerres GW
    Laryngoscope; 2003 May; 113(5):888-91. PubMed ID: 12792328
    [TBL] [Abstract][Full Text] [Related]  

  • 75. False-positive mediastinal lymph node activity on positron emission tomographic scan after adjuvant treatment of gynecologic malignancies.
    Whitson BA; Runge SJ; Groth SS; Maddaus MA
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1385-6. PubMed ID: 17467472
    [No Abstract]   [Full Text] [Related]  

  • 76. A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advanced cervical cancer.
    Small W; Vern TZ; Rademaker A; Nemcek A; Spies S; Schink JC; Singh DK; Lurain JR
    Am J Clin Oncol; 2010 Feb; 33(1):89-93. PubMed ID: 19730352
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of parenchymal tuberculosis sequelae on mediastinal lymph node staging in patients with lung cancer.
    Lee SH; Min JW; Lee CH; Park CM; Goo JM; Chung DH; Kang CH; Kim YT; Kim YW; Han SK; Shim YS; Yim JJ
    J Korean Med Sci; 2011 Jan; 26(1):67-70. PubMed ID: 21218032
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer.
    Gupta NC; Graeber GM; Rogers JS; Bishop HA
    Ann Surg; 1999 Feb; 229(2):286-91. PubMed ID: 10024112
    [TBL] [Abstract][Full Text] [Related]  

  • 79. False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET--radiological-pathological correlation.
    Shiraki N; Hara M; Ogino H; Shibamoto Y; Iida A; Tamaki T; Murase T; Eimoto T
    Ann Nucl Med; 2004 Feb; 18(1):23-8. PubMed ID: 15072180
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma.
    Flores RM; Akhurst T; Gonen M; Larson SM; Rusch VW
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):11-6. PubMed ID: 12878934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.